Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Operating Expenses: 2012-2025

Historic Operating Expenses for Phibro Animal Health (PAHC) over the last 14 years, with Jun 2025 value amounting to $296.5 million.

  • Phibro Animal Health's Operating Expenses fell 0.63% to $68.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $292.5 million, marking a year-over-year increase of 12.25%. This contributed to the annual value of $296.5 million for FY2025, which is 13.94% up from last year.
  • According to the latest figures from FY2025, Phibro Animal Health's Operating Expenses is $296.5 million, which was up 13.94% from $260.2 million recorded in FY2024.
  • Phibro Animal Health's Operating Expenses' 5-year high stood at $296.5 million during FY2025, with a 5-year trough of $196.5 million in FY2021.
  • Over the past 3 years, Phibro Animal Health's median Operating Expenses value was $260.2 million (recorded in 2024), while the average stood at $261.0 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first decreased by 4.70% in 2021, then increased by 14.92% in 2024.
  • MRY analysis of 5 years shows Phibro Animal Health's Operating Expenses stood at $196.5 million in 2021, then rose by 5.04% to $206.4 million in 2022, then grew by 9.68% to $226.4 million in 2023, then rose by 14.92% to $260.2 million in 2024, then rose by 13.94% to $296.5 million in 2025.
  • Its Operating Expenses stands at $296.5 million for FY2025, versus $260.2 million for FY2024 and $226.4 million for FY2023.